First and Second-Trimester Surgical Abortion Providers and Services in 2019: Results From the Canadian Abortion Provider Survey.

abortion delivery of health care first induced pregnancy trimester pregnancy trimester second surgical abortion surveys and questionnaires

Journal

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
ISSN: 1701-2163
Titre abrégé: J Obstet Gynaecol Can
Pays: Netherlands
ID NLM: 101126664

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 09 12 2022
revised: 11 07 2023
accepted: 02 08 2023
medline: 6 12 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: ppublish

Résumé

Our objective was to explore the workforce and clinical care of first and second-trimester surgical abortion (FTSA, STSA) providers following the publication of the updated Society of Obstetricians and Gynaecologists of Canada (SOGC) surgical abortion guidelines. We conducted a national, cross-sectional, online, self-administered survey of physicians who provided abortion care in 2019. This anonymized survey collected participant demographics, types of abortion services, and characteristics of FTSA and STSA clinical care. Through healthcare organizations using a modified Dillman technique, we recruited from July to December 2020. Descriptive statistics were generated by R Statistical Software. We present the data of 222 surgical abortion provider respondents, of whom 219 provided FTSA, 109 STSA, and 106 both. Respondents practiced in every Canadian province and territory. Most were obstetrician-gynaecologists (56.8%) and family physicians (36.0%). The majority of FTSA and STSA respondents were located in urban settings, 64.8% and 79.8%, respectively, and more than 80% practiced in hospitals. More than 1 in 4 respondents reported <5 years' experience with surgical abortion care and 93.2% followed SOGC guidelines. Noted guideline deviations included that prophylactic antibiotic use was not universal, and more than half of respondents used sharp curettage in addition to suction. Fewer than 5% of STSA respondents used mifepristone for cervical preparation. The surgical abortion workforce is multidisciplinary and rejuvenating. Education, training, and practice support, including SOGC guideline implementation, are required to optimize care and to ensure equitable FTSA and STSA access in both rural and urban regions. GESTATIONAL AGE NOTATION: weeks, weeks' gestation, gestational age (GA), e.g., 11

Identifiants

pubmed: 37558165
pii: S1701-2163(23)00498-X
doi: 10.1016/j.jogc.2023.08.001
pii:
doi:

Substances chimiques

Mifepristone 320T6RNW1F

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102188

Informations de copyright

Copyright © 2023 The Author. Published by ELSEVIER INC. on behalf of the Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.

Auteurs

Regina Renner (R)

Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC; Contraception Abortion Research Team, Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, BC. Electronic address: regina.renner@ubc.ca.

Madeleine Ennis (M)

Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC; Contraception Abortion Research Team, Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, BC.

Lauren Kean (L)

Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC; Contraception Abortion Research Team, Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, BC.

Melissa Brooks (M)

Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC; Contraception Abortion Research Team, Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, BC.

Brigid Dineley (B)

Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC; Contraception Abortion Research Team, Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, BC.

Helen Pymar (H)

Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC; Contraception Abortion Research Team, Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, BC.

Wendy V Norman (WV)

Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC; Contraception Abortion Research Team, Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, BC; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Edith Guilbert (E)

Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC; Contraception Abortion Research Team, Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, BC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH